Press Releases

Washington, D.C. Congresswoman Doris Matsui (D-CA) issued the following statement on President Trump's misguided reference to the 340B Program in the Administration's prescription drug plan released today:

"The Trump Administration's efforts to connect high prescription drug prices to the 340B program are misguided and based on inaccurate assumptions.

Washington, D.C. Today, the bipartisan Nuclear Waste Policy Amendments Act of 2018, H.R. 3053, passed the House of Representatives by a vote of 340-72.

Washington, D.C.Today, Congresswoman Doris Matsui (CA-06) delivered the following floor remarks in support of the Nuclear Waste Policy Amendments Act of 2018:

I rise today in support of the Nuclear Waste Policy Amendments Act.

Washington, D.C. Congresswoman Doris Matsui (D-CA) gave thefollowingopening remarks at today's Health Subcommittee hearing on "Improving the Coordination and Quality of Substance Use Disorder Treatment:"

This is a very important and complex issue relating to the opioid epidemic.

Washington, D.C. Today, Congresswoman Doris Matsui (D-CA) issued the following statement on the Trump Administration's announced withdrawal from the Iran nuclear agreement:

Sacramento, CA Congresswoman Doris Matsui (CA-06) issued the following statement on California's participation in a lawsuit with 17 other states and the District of Columbia over the Environmental Protection Agency's (EPA) April 2 Final Determination to weaken vehicle emissions standards:

Washington, D.C. Congresswoman Doris Matsui (D-CA) delivered the following opening remarks today at a Subcommittee on Health markup on "Opioid Legislation and H.R. 5554:"

Our Committee has a daunting, yet absolutely essential, task before us today: to make policy changes that address the opioid epidemic without creating unintended consequences.